Oculocutaneous albinism: epidemiology, genetics, skin manifestation, and psychosocial issues.
Ma EZ, Zhou AE, Hoegler KM, Khachemoune A.
Arch Dermatol Res. 2023 Mar;315(2):107-116. doi: 10.1007/s00403-022-02335-1. Epub 2022 Feb 25.
Oculocutaneous albinism.
Grønskov K, Ek J, Brondum-Nielsen K.
Orphanet J Rare Dis. 2007 Nov 2;2:43. doi: 10.1186/1750-1172-2-43.
Oculocutaneous Albinism.
Ye H, Mao K, Zhao P.
Asia Pac J Ophthalmol (Phila). 2023 Mar-Apr 01;12(2):268. doi: 10.1097/APO.0000000000000506. Epub 2022 Aug 18.
Oculocutaneous Albinism.
Bezerra Castaldelli G, Bezerra Castaldelli AJ, Anderson Castaldelli V.
JAMA Ophthalmol. 2021 Dec 1;139(12):e214068. doi: 10.1001/jamaophthalmol.2021.4068. Epub 2021 Dec 15.
Oculocutaneous albinism.
Okulicz JF, Shah RS, Schwartz RA, Janniger CK.
J Eur Acad Dermatol Venereol. 2003 May;17(3):251-6. doi: 10.1046/j.1468-3083.2003.00767.x.
Oculocutaneous albinism.
David CV.
Cutis. 2013 May;91(5):E1-4.
[Oculocutaneous and ocular albinism].
Kubasch AS, Meurer M.
Hautarzt. 2017 Nov;68(11):867-875. doi: 10.1007/s00105-017-4061-x.
Current landscape of Oculocutaneous Albinism in Japan.
Okamura K, Suzuki T.
Pigment Cell Melanoma Res. 2021 Mar;34(2):190-203. doi: 10.1111/pcmr.12927. Epub 2020 Oct 7.
Oculocutaneous albinism.
Biswas S, Lloyd IC.
Arch Dis Child. 1999 Jun;80(6):565-9. doi: 10.1136/adc.80.6.565.
Molecular outcomes, clinical consequences, and genetic diagnosis of Oculocutaneous Albinism in Pakistani population.
Shahzad M, Yousaf S, Waryah YM, Gul H, Kausar T, Tariq N, Mahmood U, Ali M, Khan MA, Waryah AM, Shaikh RS, Riazuddin S, Ahmed ZM; University of Washington Center for Mendelian Genomics (UW CMG) Consortium.
Sci Rep. 2017 Mar 7;7:44185. doi: 10.1038/srep44185.
